Atlas Trials

Effect of Genetic Variants in MATE1 and OCT3 on the Pharmacodynamics of Metformin in African Americans

Clinical trial NCT01681693 · COMPLETED

Trial details

NCT number
NCT01681693
Sponsor
University of California, San Francisco
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
HealthyType 2 Diabetes Mellitus
Start date
2010-02-01
Primary completion
2013-07-01
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.